-
Measures of trancranial magnetic evoked potentials for prediction of response to ventriculoparitoneal shunt In normal pressure hydrocephalus
-
Measuring the heterogeneity of disease progression in Parkinson’s disease with multimodal clinical milestones over 10 years in the DeNoPa cohort
-
Meige Syndrome Following COVID Infection
-
Melatonin for huntington disease (HD) gene carriers with HD-related sleep disturbance – a pilot study
-
Membrane-associated properties and ER stress alterations in LRRK2 I1371V patient iPSC derived neurons increase susceptibility to oxidative stress.
-
MER length as a predictor of motor and non-motor outcomes of STN DBS in Parkinson’s disease
-
Mesencephalic neuroglial cyst can produce clinical manifestations and a metabolic [18F] FDG PET pattern mimicking a Progressive Supranuclear Palsy Syndrome
-
Metabolic connectivity assessed by dynamic FDG-fPET acquisition in Parkinson’s disease: a multimodal fPET and fMRI study
-
Metabolic modulation of mitochondrial DNA release in cellular models of Parkin-associated Parkinson’s disease
-
Metoclopramide-induced acute dystonic reaction caused by CYP2D6 *4/*4 and CYP2D6 *10/*10 genotypes
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 186
- Next Page »